177Lu-PSMA-617 radioligand therapy and outcome in patients with metastasized castration-resistant prostate cancer
Crossref DOI link: https://doi.org/10.1007/s00259-017-3751-z
Published Online: 2017-06-17
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bräuer, Axel
Grubert, Lena Sophie
Roll, Wolfgang
Schrader, Andres Jan
Schäfers, Michael
Bögemann, Martin
Rahbar, Kambiz
License valid from 2017-06-17